Mobile : +91-8451008897

Working Hour: (10:00 am–7:00 pm)

E-mail: info@shubhampharma.com

DAKLINZA-NATDAC

Shubham Pharmaceutical
DAKLINZA-NATDAC

Product Code : 46

Product Description

Daklinza:

It contains the Drug / Molecule Daclatasvir.

DACLATASVIR has been innovated by BRISTOL MYERS SQUIBB with the brand name DAKLINZA.

USAGE & DESCRIPTION :

DAKLINZA has used with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection

 

Active Ingredients
Daclatasvir
Brand Name
Daklinza
International Brand Name
 
Packing
1*28
Doses Form
Tablets (IN Plastic Bottle)
Strength
30 Mg & 60 Mg
Mfg By
Bristol Myers Squibb
 
 

CLINICAL APPLICATIONS:

It inhibits the Hepatitis C Virus (HCV) nonstructural protein by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

STORAGE:

Store DAKLINZA tablets at 25°C, with excursions permitted between 15°C and 30°C.

Natdac is generic version of DAKLINZABoth contain the same Drug / molecule Daclatasvir.

NATDAC :

Its contains Drug / Molecule Daclatasvir.

NATDAC is generic version of DAKLINZA.

USAGE & DESCRIPTION :

NATDAC has used with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCVgenotype 1 or genotype 3 infection.

 

Active Ingredients
DACLATASVIR
Brand Name
NATDAC
International Brand Name
DAKINZA
Packing
1*28
Doses Form
TABLETS (IN PLASTIC BOTTLE)
Strength
30 MG & 60 MG
Mfg By
NATCO PHARMA LTD. (INDIA)
 

CLINICAL APPLICATIONS:

It inhibits the Hepatitis C Virus (HCVnonstructural protein by targeting two steps of the viral replication processenabling rapid decline of HCV RNA.

STORAGE:

Store below 25°C.

SHUBHAM PHARMACEUTICAL

Contact Us !!

24x7

Front Hall, 2nd Floor, Mimraj Building, 405, Kalbadevi Road, Mumbai – 400002, Maharashtra, India

Phone :91-22-22005519

Mr Ashok Mehra (Marketing Manager)

Mobile :08451008897

Copyright © 2018 SHUBHAM PHARMACEUTICAL

Designed & Maintained by Biggo Digital